Zamzetoclax

Zamzetoclax CAS 2388470-64-0 MF C38H46ClN5O6S MW736.32 N-[(3′R,4S,6′R,7′S,8′E,11′S)-7-chloro-7′-methoxy-11′-methyl-13′,15′-dioxospiro[2,3-dihydro-1H-naphthalene-4,22′-20-oxa-13λ6-thia-1,14-diazatetracyclo[14.7.2.03,6.019,24]pentacosa-8,13,16(25),17,19(24)-pentaene]-13′-yl]-3-methoxy-1-methylpyrazole-4-carboxamide 1H-Pyrazole-4-carboxamide, N-[(1’S,10S,12S,14E,16S,16aR,18aR)-6′-chloro-3′,4′,8,11,12,13,16,16a,17,18,18a,19-dodecahydro-16-methoxy-12-methyl-10-oxido-8-oxospiro[5,7-etheno-1H-10lambda4-cyclobut[i][1,4]oxazepino[3,4-f][1,2,7]thiadiazacyclohexadecine-2(3H),1′(2’H)-naphthalen]-10-yl]-3-methoxy-1-methyl- N-[(1’S,10S,12S,14E,16S,16aR,18aR)-6′-Chloro-3′,4′,8,11,12,13,16,16a,17,18,18a,19-dodecahydro-16-methoxy-12-methyl-10-oxido-8-oxospiro[5,7-etheno-1H-10lambda4-cyclobut[i][1,4]oxazepino[3,4-f][1,2,7]thiadiazacyclohexadecine-2(3H),1′(2’H)-naphthalen]-10-yl]-3-methoxy-1-methyl-1H-pyrazole-4-carboxamide B-cell lymphoma 2 (Bcl-2) inhibitor, antineoplastic, RRS8GZU2UN Zamzetoclax (compound 1) is a potential Mcl-1 inhibitor. REFDiscovery of an Oral, Beyond-Rule-of-Five Mcl-1 Protein–Protein Interaction Modulator with the Potential of Treating Hematological Malignancies Publication Name: Journal of Medicinal Chemistry, Publication Date: 2023-04-28, PMID: 37114951 DOI: 10.1021/acs.jmedchem.2c01953 SYN WO 2019/222112 https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2019222112&_cid=P12-MJ7Z15-98773-1 Example 154 [0447] … Continue reading Zamzetoclax